Strides Pharma Shares Up 2% After Shareholders Approve Specialty CDMO Unit
Shares of Strides Pharma Science Ltd. rose by 2% to reach a day’s high of Rs 1,382 on 11th September after the company’s equity shareholders...
Tag : Strides Pharma Science Ltd
Strides Pharma Rises Nearly 4% on USFDA Approval for Respiratory Drug from Singapore Arm
Shares of Strides Pharma Science Ltd. surged nearly by 4% to a day’s high of Rs 1,395 on 6th September, after the company’s subsidiary received...
Strides Pharma Trade Lower Despite the Transfer of Bengaluru Facility to Syngene
Shares of Strides Pharma were trading in the red and 1% below on 4 December despite the company announcing the closure of its transaction with...
Strides Pharma Shares Gain 3% on Receiving USFDA Approval for Seizure Drug
Shares of Strides Pharma were trading almost 4% higher on 21 November after the company announced receiving approval from USFDA (US Food & Drug Administration)...
Strides Pharma Shares Tumble 2% on Weak Q2 Earnings
Shares of Strides Pharma were trading 2% below on 30 October after the company announced its quarterly earnings for the July-September quarter. The company...
Strides Pharma Shares Tumble 2% as 1.5% Equity Change Hands
Strides Pharma Science shares were trading in the red on 6 October after 1.5% equity of the company changed hands. Around 13.75 lakh shares of...
Strides Pharma Shares Tumble 3% on Spin-Off of CDMO
Strides Pharma shares fell 3% on 26 September after the company announced its plans to spin off its Contract Development and Manufacturing Organisation (CDMO) and...
Strides Pharma Shares Hit 52-Week High on Tentative USFDA Approval
Stride Pharma shares hit a 52-week high of Rs 522.75 on 15 September after its wholly owned subsidiary, Stride Pharma Global Pte. Ltd., received tentative...
Strides Pharma to Sell Manufacturing Unit to Syngene International for Rs 702 crore
Strides Pharma Science on Monday declared that it had entered a binding contract to sell the biologics Unit-3 manufacturing facility of its associate company Stelis...
Stride Pharma Science June Quarter Net Loss Narrows to Rs 163 Crore
Strides Pharma Science Ltd has reported a consolidated net loss of Rs 163.4 crore in the first quarter ended in June 2022, compensated by higher...
